×
About 7,660 results

ALLMedicine™ Hepatic Encephalopathy Center

Research & Reviews  3,701 results

Trihydroxycholanoyl-taurine in brains of rodents with hepatic encephalopathy.
https://doi.org/10.1002/jms.4729
Journal of Mass Spectrometry : JMS; Schnelle ANW, Richardson LT et. al.

May 4th, 2021 - Hepatic encephalopathy (HE), a neurological disease resulting from liver failure, is difficult to manage and its causes are unclear. Bile acids have been postulated to be involved in the provenance and progression of various diseases including HE....

Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encep...
https://doi.org/10.1016/j.clinimag.2021.04.034
Clinical Imaging; Dai R, Sag AA et. al.

May 3rd, 2021 - Proton pump inhibitor (PPI) use is a potential risk factor for hepatic encephalopathy (HE), but few studies have examined the effect on post-TIPS HE. The purpose of this study was to determine whether PPIs are associated with increased rates of po...

Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhos...
https://doi.org/10.14309/ajg.0000000000001275
The American Journal of Gastroenterology; Thornton C, Somayaji R et. al.

Apr 30th, 2021 - To describe the characteristics and outcomes of children with cystic fibrosis (CF) hospitalized with cirrhosis in the United States. We conducted a population-based cohort study of hospitalizations among children with CF using the 2016 Kid's Inpat...

Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits...
https://doi.org/10.1016/j.jep.2021.114141
Journal of Ethnopharmacology; Khalil HMA, Eliwa HA et. al.

Apr 27th, 2021 - Ashwagandha (ASH) is one of the medicinal plants that is used in traditional Indian, Ayurvedic and Unani medicines for their broad range of pharmacological activities including tonic, aphrodisiac, energy stimulant, and counteracting chronic fatigu...

2021 ISHEN Guidelines on Animal Models of Hepatic Encephalopathy.
https://doi.org/10.1111/liv.14911
Liver International : Official Journal of the Internation... DeMorrow S, Cudalbu C et. al.

Apr 26th, 2021 - This working group of the International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) was commissioned to summarize and update current efforts in the development and characterization of animal models of hepatic encephalopathy (...

see more →

Guidelines  23 results

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy,...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160350
Clinical and Molecular Hepatology;

Jan 10th, 2020 - KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications.|2020| ,|

Chinese guidelines on management of hepatic encephalopathy in cirrhosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767982
World Journal of Gastroenterology; Xu XY, Ding HG et. al.

Oct 2nd, 2019 - The Chinese Society of Hepatology developed the current guidelines on the management of hepatic encephalopathy in cirrhosis based on the published evidence and the panelists' consensus. The guidelines provided recommendations for the diagnosis and...

Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediat...
https://doi.org/10.1016/j.bbmt.2017.08.035
Biology of Blood and Marrow Transplantation : Journal of ... Ovchinsky N, Frazier W et. al.

Sep 5th, 2017 - Some patients with veno-occlusive disease (VOD) have multiorgan dysfunction, and multiple teams are involved in their daily care in the pediatric intensive care unit. Cardiorespiratory dysfunction is critical in these patients, requiring immediate...

How to diagnose and manage hepatic encephalopathy: a consensus statement on roles and r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885589
European Journal of Gastroenterology & Hepatology; Shawcross DL, Dunk AA et. al.

Nov 25th, 2015 - Hepatic encephalopathy is defined as brain dysfunction caused by liver insufficiency and/or portosystemic shunting. Symptoms include nonspecific cognitive impairment, personality changes and changes in consciousness. Overt (symptomatic) hepatic en...

Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Ass...
https://www.aasld.org/sites/default/files/guideline_documents/hepaticencephalopathy82014.pdf
Hendrik Vilstrup, Piero Amodio et. al.

Jul 31st, 2014 - Hepatic encephalopathy (HE) is a frequent complication and one of the most debilitating manifestations of liver disease, severely affecting the lives of patients and their caregivers. Furthermore, cognitive impairment associated with cirrhosis res.

see more →

Drugs  7 results see all →

Clinicaltrials.gov  3,807 results

Trihydroxycholanoyl-taurine in brains of rodents with hepatic encephalopathy.
https://doi.org/10.1002/jms.4729
Journal of Mass Spectrometry : JMS; Schnelle ANW, Richardson LT et. al.

May 4th, 2021 - Hepatic encephalopathy (HE), a neurological disease resulting from liver failure, is difficult to manage and its causes are unclear. Bile acids have been postulated to be involved in the provenance and progression of various diseases including HE....

Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encep...
https://doi.org/10.1016/j.clinimag.2021.04.034
Clinical Imaging; Dai R, Sag AA et. al.

May 3rd, 2021 - Proton pump inhibitor (PPI) use is a potential risk factor for hepatic encephalopathy (HE), but few studies have examined the effect on post-TIPS HE. The purpose of this study was to determine whether PPIs are associated with increased rates of po...

Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhos...
https://doi.org/10.14309/ajg.0000000000001275
The American Journal of Gastroenterology; Thornton C, Somayaji R et. al.

Apr 30th, 2021 - To describe the characteristics and outcomes of children with cystic fibrosis (CF) hospitalized with cirrhosis in the United States. We conducted a population-based cohort study of hospitalizations among children with CF using the 2016 Kid's Inpat...

Ashwagandha (Withania somnifera) root extract attenuates hepatic and cognitive deficits...
https://doi.org/10.1016/j.jep.2021.114141
Journal of Ethnopharmacology; Khalil HMA, Eliwa HA et. al.

Apr 27th, 2021 - Ashwagandha (ASH) is one of the medicinal plants that is used in traditional Indian, Ayurvedic and Unani medicines for their broad range of pharmacological activities including tonic, aphrodisiac, energy stimulant, and counteracting chronic fatigu...

2021 ISHEN Guidelines on Animal Models of Hepatic Encephalopathy.
https://doi.org/10.1111/liv.14911
Liver International : Official Journal of the Internation... DeMorrow S, Cudalbu C et. al.

Apr 26th, 2021 - This working group of the International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) was commissioned to summarize and update current efforts in the development and characterization of animal models of hepatic encephalopathy (...

see more →

News  121 results

Rifaximin May Prevent Hepatic Encephalopathy After TIPS Placement for Cirrhosis
https://www.medscape.com/viewarticle/945312

Feb 4th, 2021 - NEW YORK (Reuters Health) - The antibiotic rifaximin given before and after transjugular intrahepatic portosystemic shunt (TIPS) placement helped prevent hepatic encephalopathy (HE) in a placebo-controlled trial. "TIPS is a very effective treatmen...

Inner demons
https://www.mdedge.com/gihepnews/article/212611/mixed-topics/inner-demons?channel=41022

Dec 1st, 2019 - Julia Brennan sings about inner demons. They just won’t go away and they don’t play fair with angels.

Blocking TLR9 may halt brain edema in acute liver failure
https://www.mdedge.com/gihepnews/article/211698/liver-disease/blocking-tlr9-may-halt-brain-edema-acute-liver-failure?channel=346
Will Pass, MDedge News

Nov 6th, 2019 - A toll-like receptor 9 (TLR9) antagonist may eventually be used to combat brain edema in acute liver failure, according to investigators. This prediction is based on results of a recent study involving mouse models, which showed that ODN2088, a TL.

New Treatments Where We Desperately Need Them, and Other Noteworthy Data: DDW 2019
https://www.staging.medscape.com/viewarticle/914363

Jun 24th, 2019 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. At the recently concluded 50th annual Digestive Disease Week, se...

New Treatments Where We Desperately Need Them, and Other Noteworthy Data: DDW 2019
https://www.medscape.com/viewarticle/914363

Jun 24th, 2019 - This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School in Norfolk, Virginia. At the recently concluded 50th annual Digestive Disease Week, se...

see more →

Patient Education  1 results see all →